NSEGeneral Updates2d ago · 29 Jul 2026, 06:34 pm
General Updates
Jagsonpal Pharmaceuticals Limited · JAGSNPHARM
✦ AI SummaryBonus/Split
Jagsonpal Pharmaceuticals Limited has informed the Exchange about the grant of 1,20,000 employee stock options under Jagsonpal Pharmaceuticals Limited Employees Stock Option Plan, 2022.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Jagsonpal Pharmaceuticals Limited has informed the Exchange about 'Grant of 1,20,000 ESOP under JPL ESOP Plan 2022
Attachments (1)
📄pdf
Download →
JAGSNPHARM_29072026183401_ESOPGrantIntimation_Signed_final.pdf
View document text
July 29, 2026
The Department of Corporate Services- Listing The Department of Corporate Services- Listing
BSE Ltd, National Stock Exchange of India Ltd
Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G,
Dalal Street Bandra Kurla Complex,
Mumbai-400 001 Bandra (E) Mumbai – 400 051
Scrip Code: 507789 Symbol: JAGSNPHARM
Subject: Intimation for grant of Employee Stock Options
Dear Sir/ Madam,
We wish to inform you that the Nomination and Remuneration Committee of the Board of Directors at their
meeting held on July 29, 2026 has approved the grant of 1,20,000 employee stock options under Jagsonpal
Pharmaceuticals Limited Employees Stock Option Plan, 2022 at an exercise price of Rs. 179.25/- per option.
The said options, which are convertible into equivalent number of equity shares of Rs. 2.00/- each, will vest in 4
equal annual tranches commencing from the first anniversary of the grant.
We request you to take the above on record.
Thanking you,
For Jagsonpal Pharmaceuticals Limited
Pratham Rawal
Company Secretary & Compliance officer